Evidence map›Paper›PMID 35071415›Full record

ArticleAnnals of translational medicine2021

RefineNet-based automatic delineation of the clinical target volume and organs at risk for three-dimensional brachytherapy for cervical cancer.

Xue Jiang, Fang Wang, Ying Chen, Senxiang Yan

Abstract read
In one paragraph

Article in Annals of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Systematic review of artificial intelligence in brachytherapy.Journal of contemporary brachytherapy · 2026
    Review
  4. Review
  5. Article
  6. A review of artificial intelligence in brachytherapy.Journal of applied clinical medical physics · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Cervical cancer segmentation based on medical images: a literature review.Quantitative imaging in medicine and surgery · 2024
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xue JiangDepartment of Radiation Oncology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Fang WangDepartment of Radiation Oncology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ying ChenDepartment of Radiation Oncology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Senxiang YanDepartment of Radiation Oncology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years, high-precision image-guided intensity-modulated radiation therapy combined with three-dimensional (3D) high-dose-rate (HDR) brachytherapy (BT) has become a recommended technique for radical radiotherapy for cervical cancer. This study first employed contrast-limited adaptive histogram equalization (CLAHE) for preprocessing of input data to achieve image enhancement. In this way, rapid and accurate automatic delineation of the clinical target volume (CTV) and organs at risk (OARs) in 3D BT for cervical cancer was achieved.

methodsTwo hundred cervical cancer patients who underwent radical radiotherapy from January 2016 to December 2018 were selected. After collecting the computed tomography (CT) image data of a patient, we constructed the radiotherapy CTV and OAR image libraries. A RefineNet-based deep learning protocol was used to segment the CTV and OARs for 3D BT for cervical cancer. In this study, a total of 1,000 rounds of training were carried out, and the model with the best performance was selected for subsequent iterative tuning. Finally, the clinical test was carried out, in which the CT images of 10 cases were tested one by one. The manual delineation results and the model output results for the CTV and OARs were compared to measure the performance of the model.

resultsCompared with the manually delineated CTV, the RefineNet model-based segmented CTV had a higher Dice similarity coefficient (DSC), Hausdorff distance (HD), and overlap index (OI), which were 0.861, 6.005, and 0.839, respectively. For OARs, the RefineNet-based model obtained the best results for bladder segmentation (DSC: 85.96%), respectively. The mean duration of RefineNet-based automatic contour processing of the CTV was 70 s, and the mean durations of RefineNet-based automatic delineation of the bladder, rectum, sigmoid colon, and small intestine were 67, 67.4, 63.8, and 60.8 s, respectively. The total time saved by RefineNet was approximately 60%.

conclusionsThe RefineNet-based automatic delineation model for 3D BT for cervical cancer is a stable and highly consistent automatic delineation algorithmic model that has the potential to improve the consistency of target region delineation, simplify the radiotherapy procedure, and achieve rapid and accurate automatic delineation of CTVs and OARs.

Indexed as

automatic delineationcervical cancerRefineNet networkthree-dimensional brachytherapy (3D BT)

Identifiers

PMID35071415
PMCPMC8743698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.